|
Video: What is a Stock Split?
|
|
BioNTech develops immunotherapies for cancer and other diseases. Co.'s immunotherapy product candidates span the following four drug classes: messenger ribonucleic acid (mRNA) therapeutics, in which it is utilizing mRNA to deliver genetic information to cells; cell therapies, in which it is developing a range of cell therapies, including chimeric antigen receptorT cells, neoantigen-based T cell therapies and T cell receptor therapies; antibodies, in which it is developing antibodies that are designed to target immune checkpoints that modulate the patient's immune response to cancer; and small molecule immunomodulators, which is for the treatment of solid tumors in clinical testing. According to our BioNTech SE stock split history records, BioNTech SE has had 0 splits. | |
|
BioNTech SE (BNTX) has 0 splits in our BioNTech SE stock split history database.
Looking at the BioNTech SE stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioNTech SE shares, starting with a $10,000 purchase of BNTX, presented on a split-history-adjusted basis factoring in the complete BioNTech SE stock split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
10/11/2019 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$13.82 |
|
End price/share: |
$86.71 |
|
Starting shares: |
723.59 |
|
Ending shares: |
733.23 |
|
Dividends reinvested/share: |
$2.11 |
|
Total return: |
535.79% |
|
Average Annual Total Return: |
50.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$63,577.73 |
|
Years: |
4.54 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/11/2019 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$13.82 |
|
End price/share: |
$86.71 |
|
Dividends collected/share: |
$2.11 |
|
Total return: |
542.70% |
|
Average Annual Total Return: |
50.62% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$64,272.59 |
|
Years: |
4.54 |
|
|
|
|
|